BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12522449)

  • 21. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
    Utsunomiya A; Choi I; Chihara D; Seto M
    Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.
    Ishida T; Fujiwara H; Nosaka K; Taira N; Abe Y; Imaizumi Y; Moriuchi Y; Jo T; Ishizawa K; Tobinai K; Tsukasaki K; Ito S; Yoshimitsu M; Otsuka M; Ogura M; Midorikawa S; Ruiz W; Ohtsu T
    J Clin Oncol; 2016 Dec; 34(34):4086-4093. PubMed ID: 27621400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.
    Tsukasaki K; Ikeda S; Murata K; Maeda T; Atogami S; Sohda H; Momita S; Jubashi T; Yamada Y; Mine M
    Leuk Res; 1993 Feb; 17(2):157-66. PubMed ID: 8429692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
    Bazarbachi A; Hermine O
    Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
    Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
    Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adult T-cell leukemia/lymphoma. Therapeutic aspects].
    Besson C; Plumelle Y; Arnulf B; Gonin C; Panelatti G; Bazarbachi A; Hermine O
    Presse Med; 2001 Feb; 30(5):243-5. PubMed ID: 12385063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ATL (adult T-cell leukemia/lymphoma)].
    Ichimaru M; Tsukazaki K; Ikeda S
    Rinsho Ketsueki; 1989 Aug; 30(8):1208-11. PubMed ID: 2601035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma. Results of a preliminary study at UHWI-Mona.
    Wharfe G; Hanchard B
    West Indian Med J; 1996 Dec; 45(4):107-9. PubMed ID: 9033228
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Hachiman M; Yoshimitsu M; Ezinne C; Kuroki A; Kozako T; Arima N
    Oncol Lett; 2018 Jul; 16(1):1305-1311. PubMed ID: 30061950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
    Mone A; Puhalla S; Whitman S; Baiocchi RA; Cruz J; Vukosavljevic T; Banks A; Eisenbeis CF; Byrd JC; Caligiuri MA; Porcu P
    Blood; 2005 Nov; 106(10):3380-2. PubMed ID: 16076875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
    Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A
    Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Wassmann B; Scheuring U; Pfeifer H; Binckebanck A; Käbisch A; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Leukemia; 2003 Oct; 17(10):1919-24. PubMed ID: 14513038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
    Ishida T; Joh T; Uike N; Yamamoto K; Utsunomiya A; Yoshida S; Saburi Y; Miyamoto T; Takemoto S; Suzushima H; Tsukasaki K; Nosaka K; Fujiwara H; Ishitsuka K; Inagaki H; Ogura M; Akinaga S; Tomonaga M; Tobinai K; Ueda R
    J Clin Oncol; 2012 Mar; 30(8):837-42. PubMed ID: 22312108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
    Malpica L; Enriquez DJ; Castro DA; Peña C; Idrobo H; Fiad L; Prates M; Otero V; Biglione M; Altamirano M; Sandival-Ampuero G; Aviles-Perez U; Meza K; Aguirre-Martinez L; Cristaldo N; Maradei JL; Guanchiale L; Soto P; Viñuela JL; Cabrera ME; Paredes SR; Riva E; Di Stefano M; Noboa A; Choque JA; Candelaria M; Von Glasenapp A; Valvert F; Torres-Viera MA; Castillo JJ; Ramos JC; Villela L; Beltran BE
    JCO Glob Oncol; 2021 Jul; 7():1151-1166. PubMed ID: 34270330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).
    Tsukasaki K; Tobinai K; Shimoyama M; Kozuru M; Uike N; Yamada Y; Tomonaga M; Araki K; Kasai M; Takatsuki K; Tara M; Mikuni C; Hotta T;
    Int J Hematol; 2003 Feb; 77(2):164-70. PubMed ID: 12627852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.
    Malpica L; Pimentel A; Reis IM; Gotuzzo E; Lekakis L; Komanduri K; Harrington T; Barber GN; Ramos JC
    Blood Adv; 2018 Mar; 2(6):607-620. PubMed ID: 29545256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.
    Hermine O; Bouscary D; Gessain A; Turlure P; Leblond V; Franck N; Buzyn-Veil A; Rio B; Macintyre E; Dreyfus F
    N Engl J Med; 1995 Jun; 332(26):1749-51. PubMed ID: 7760891
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
    Katsuya H; Ishitsuka K
    J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.